Douglas K. Graham

A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation

Susan Sather, Karla D. Kenyon, Jerry B. Lefkowitz et al. · Blood · 2006 · 320 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

K E Ware, Trista K. Hinz, Emily K. Kleczko et al. · Oncogenesis · 2013 · 256 citations · Full text

Medicine, Oncology, Pharmacology +17

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer

Rachel M.A. Linger, Richard A. Cohen, Christopher T. Cummings et al. · Oncogene · 2012 · 217 citations

Life Sciences, Cancer Biology, Oncology +16

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

Rebecca S. Cook, Kristen M. Jacobsen, Anne Wofford et al. · Journal of Clinical Investigation · 2013 · 183 citations · Full text

Medicine, Oncology, Pharmacology +17

<b>UNC2025</b>, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor

Weihe Zhang, Deborah DeRyckere, Debra M. Hunter et al. · Journal of Medicinal Chemistry · 2014 · 160 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14